Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 241,208 | 312,012 | 125,297 | 127,598 | 126,003 |
| Marketable Securities | 625,170 | 588,753 | 265,593 | 110,250 | 119,658 |
| TOTAL | $877,803 | $910,355 | $397,244 | $245,008 | $252,884 |
| Non-Current Assets | |||||
| PPE Net | 5,298 | 5,457 | 5,274 | 5,850 | 6,453 |
| Other Non-Current Assets | 19,905 | 21,795 | 23,415 | 23,959 | 24,461 |
| TOTAL | $25,203 | $27,252 | $28,689 | $29,809 | $30,914 |
| Total Assets | $903,006 | $937,607 | $425,933 | $274,817 | $283,798 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,744 | 9,504 | 16,029 | 16,625 | 14,154 |
| Accrued Expenses | 42,854 | 52,902 | 44,511 | 40,139 | 33,553 |
| TOTAL | $57,981 | $63,953 | $62,246 | $58,422 | $49,318 |
| Non-Current Liabilities | |||||
| Long Term Debt | 223,173 | 222,895 | 44,250 | N/A | N/A |
| Other Non-Current Liabilities | 14,159 | 14,388 | 16,973 | 17,410 | 15,485 |
| TOTAL | $237,332 | $237,283 | $61,223 | $61,359 | $15,485 |
| Total Liabilities | $295,313 | $301,236 | $123,469 | $119,781 | $64,803 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,868 | 162,309 | 142,377 | 139,701 | 113,857 |
| Common Shares | 171 | 161 | 141 | 114 | 114 |
| Retained earnings | -1,285,772 | -1,188,420 | -1,085,928 | -1,004,998 | -931,469 |
| Other shareholders' equity | 64,338 | 89,748 | 108,123 | 107,928 | 108,329 |
| TOTAL | $607,693 | $636,371 | $302,464 | $155,036 | $218,995 |
| Total Liabilities And Equity | $903,006 | $937,607 | $425,933 | $274,817 | $283,798 |